tiprankstipranks
Royalty Management Holding (RMCO)
NASDAQ:RMCO
US Market

Royalty Management Holding (RMCO) AI Stock Analysis

Compare
20 Followers

Top Page

RM

Royalty Management Holding

(NASDAQ:RMCO)

50Neutral
RMCO's stock score reflects strong revenue growth and improved cash flow, offset by ongoing profitability challenges. Positive technical indicators suggest some market confidence, but the negative P/E ratio points to valuation concerns. Overall, while there are signs of improvement, financial and valuation challenges weigh heavily on the stock.

Royalty Management Holding (RMCO) vs. S&P 500 (SPY)

Royalty Management Holding Business Overview & Revenue Model

Company DescriptionRoyalty Management Holding (RMCO) is a diversified company specializing in the management and monetization of intellectual property and royalty interests across various sectors, including entertainment, technology, and natural resources. The company focuses on acquiring, managing, and optimizing royalty streams to maximize returns for its stakeholders. RMCO leverages its expertise in royalty management to provide innovative solutions and strategic partnerships that enhance the value of its assets.
How the Company Makes MoneyRMCO generates revenue primarily through the acquisition and management of royalty interests. The company invests in a diverse portfolio of intellectual property rights, including music, film, patents, and natural resource royalties, and collects ongoing payments from these assets. Revenue streams include licensing fees, royalty payments, and profit-sharing arrangements. RMCO also partners with industry leaders to enhance the monetization potential of its assets, leveraging strategic alliances and marketing initiatives to drive growth. The company's earnings are further supported by its ability to identify undervalued royalty opportunities and optimize their performance through active management and strategic investments.

Royalty Management Holding Financial Statement Overview

Summary
Royalty Management Holding exhibits strong revenue growth but is hindered by persistent profitability issues and operational inefficiencies. While the balance sheet shows good equity levels, high reliance on debt financing requires caution. Cash flow challenges persist, indicating a need for better cash management to support sustainable growth.
Income Statement
45
Neutral
The company has shown significant revenue growth with total revenue increasing from 361,625 in the annual report to 675,940 in the TTM period, marking a robust growth trajectory. However, the persistent negative net income and EBIT margins indicate ongoing challenges in achieving profitability. The negative EBITDA and EBIT suggest that operating expenses remain high relative to revenues, which is a concern for future profitability.
Balance Sheet
60
Neutral
The company's equity ratio is healthy, with stockholders' equity representing a significant portion of total assets. However, the debt-to-equity ratio is relatively high, indicating reliance on debt financing which could pose future risks if not managed carefully. The return on equity remains negative due to consecutive periods of net losses, impacting overall shareholder value.
Cash Flow
50
Neutral
Operating cash flow remains negative, reflecting ongoing operational challenges. The company has improved its free cash flow compared to the previous year, but it remains negative, which could impact future growth initiatives. The ratio of operating cash flow to net income is unfavorably low, indicating inefficiencies in converting income into cash flow.
Breakdown
TTMDec 2023Dec 2022Dec 2021
Income StatementTotal Revenue
675.94K361.63K172.69K0.00
Gross Profit
479.19K109.66K169.26K0.00
EBIT
-1.08M-1.69M-1.50M-1.02M
EBITDA
-674.62K-1.28M1.23M-113.15K
Net Income Common Stockholders
-913.93K-2.07M1.20M-113.15K
Balance SheetCash, Cash Equivalents and Short-Term Investments
195.49K195.49K433.34K293.15K
Total Assets
13.61M13.61M12.50M251.64K
Total Debt
2.40M2.40M3.83M174.27K
Net Debt
2.21M2.21M3.40M-118.88K
Total Liabilities
3.99M3.99M4.31M221.67K
Stockholders Equity
9.62M9.62M8.18M29.97K
Cash FlowFree Cash Flow
-1.07M-1.91M7.19M-1.37M
Operating Cash Flow
-949.55K-1.91M7.87M-1.37M
Investing Cash Flow
2.67M6.86M-11.14M-106.12M
Financing Cash Flow
-2.10M-5.26M3.89M107.78M

Royalty Management Holding Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.06
Price Trends
50DMA
1.08
Negative
100DMA
1.06
Negative
200DMA
0.99
Positive
Market Momentum
MACD
0.02
Negative
RSI
53.44
Neutral
STOCH
59.38
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RMCO, the sentiment is Negative. The current price of 1.06 is above the 20-day moving average (MA) of 1.05, below the 50-day MA of 1.08, and above the 200-day MA of 0.99, indicating a neutral trend. The MACD of 0.02 indicates Negative momentum. The RSI at 53.44 is Neutral, neither overbought nor oversold. The STOCH value of 59.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RMCO.

Royalty Management Holding Risk Analysis

Royalty Management Holding disclosed 1 risk factors in its most recent earnings report. Royalty Management Holding reported the most risks in the “Legal & Regulatory” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Royalty Management Holding Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
SBSBR
79
Outperform
$970.55M12.19922.55%8.07%4.88%5.15%
77
Outperform
$18.33B16.6312.75%2.67%-3.85%-24.34%
63
Neutral
$14.39B9.818.95%4.37%16.38%-11.64%
50
Neutral
$15.86M108.82-0.88%65.21%98.07%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RMCO
Royalty Management Holding
1.00
-0.17
-14.53%
SBR
Sabine Royalty
61.79
-0.84
-1.34%
RPRX
Royalty Pharma
31.79
3.46
12.21%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.